FDA-Drug2026-07-08Class IIMISBRANDING
Accord Healthcare levothyroxine 300 mcg tablets recalled for subpotency
What this means
Accord Healthcare is recalling one lot of levothyroxine sodium 300 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients who need it to manage thyroid conditions.
- Check if your levothyroxine bottles match lot # D2401522 with expiration 06/2026 (NDC 16729-458-15).
- Contact your pharmacy or doctor if you have this lot — do not stop taking your medication without guidance.
- Your pharmacist or doctor can provide a replacement or verify if your supply is safe.
The agency's original wording
Hazard
Subpotent Drug
Intended for
Adults
Illnesses reported
None reported
Sold states
US Nationwide.
Affected count
6432 bottles
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Products
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0656-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.